Paper36835537
STING Agonist-Induced Skin Inflammation Is Exacerbated with Prior Systemic Innate Immune Activation.
Pyclik M and 4 others. Int J Mol Sci, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. STING Agonist-Induced Skin Inflammation Is Exacerbated with Prior Systemic Innate Immune Activation. Papers, record 36835537. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36835537
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- STING Agonist-Induced Skin Inflammation Is Exacerbated with Prior Systemic Innate Immune Activation.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dermatitis | Major topic |
| Immunity, Innate | Major topic |
| Membrane Proteins | Major topic |
| Animals | |
| Mice | |
| Cytokines | |
| Inflammation | |
| Interferons | |
| STING Protein |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 9172 | Oklahoma Medical Research Foundation | PubMed |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26824743 | TSLP Is a Potential Initiator of Collagen Synthesis and an Activator of CXCR4/SDF-1 Axis in Keloid Pathogenesis. | J Invest Dermatol | 2016 | https://conductscience.org/library/papers/26824743 | PubMed |
| 2 | 32477956 | Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/32477956 | PubMed |
| 3 | 30944222 | Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30944222 | PubMed |
| 4 | 33833439 | The cGAS-STING pathway as a therapeutic target in inflammatory diseases. | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/33833439 | PubMed |
| 5 | 32560971 | Animal models of psoriasis-highlights and drawbacks. | J Allergy Clin Immunol | 2021 | https://conductscience.org/library/papers/32560971 | PubMed |
| 6 | 25029335 | Activated STING in a vascular and pulmonary syndrome. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25029335 | PubMed |
| 7 | 34010139 | A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34010139 | PubMed |
| 8 | 33081170 | Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy. | J Clin Med | 2020 | https://conductscience.org/library/papers/33081170 | PubMed |
| 9 | 35487062 | STING activation promotes inflammatory response and delays skin wound healing in diabetic mice. | Biochem Biophys Res Commun | 2022 | https://conductscience.org/library/papers/35487062 | PubMed |
| 10 | 2469439 | Decay-accelerating factor: biochemistry, molecular biology, and function. | Annu Rev Immunol | 1989 | https://conductscience.org/library/papers/2469439 | PubMed |
| 11 | 30679970 | Phenotypic changes of lymphocyte populations in psoriasiform dermatitis animal model. | Exp Ther Med | 2019 | https://conductscience.org/library/papers/30679970 | PubMed |
| 12 | 35338116 | STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS). | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35338116 | PubMed |
| 13 | 32455939 | Polyinosinic: Polycytidylic Acid and Murine Cytomegalovirus Modulate Expression of Murine IL-10 and IL-21 in White Adipose Tissue. | Viruses | 2020 | https://conductscience.org/library/papers/32455939 | PubMed |
| 14 | 34010142 | Pharmacological activation of STING blocks SARS-CoV-2 infection. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34010142 | PubMed |
| 15 | 33444702 | Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. | Antiviral Res | 2021 | https://conductscience.org/library/papers/33444702 | PubMed |
| 16 | 30405246 | Design of amidobenzimidazole STING receptor agonists with systemic activity. | Nature | 2018 | https://conductscience.org/library/papers/30405246 | PubMed |
| 17 | 34537189 | Cytosolic DNA‒Mediated STING-Dependent Inflammation Contributes to the Progression of Psoriasis. | J Invest Dermatol | 2022 | https://conductscience.org/library/papers/34537189 | PubMed |
| 18 | 32825447 | Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32825447 | PubMed |
| 19 | 34460100 | The STING antagonist H-151 ameliorates psoriasis via suppression of STING/NF-κB-mediated inflammation. | Br J Pharmacol | 2021 | https://conductscience.org/library/papers/34460100 | PubMed |
| 20 | 21115693 | Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. | J Exp Med | 2010 | https://conductscience.org/library/papers/21115693 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41454071 | Yinqiao powder effectively alleviates acute lung injury via regulating cGAS-STING signaling pathway. | Front Med | 2025 | https://conductscience.org/library/papers/41454071 | PubMed |
| 41007722 | STING-Activating Nanoparticles Combined with PD-1/PD-L1 Blockade: A Synergistic Approach in Cancer Immunotherapy. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007722 | PubMed |
| 40552157 | Targeting the cGAS-STING pathway: emerging strategies and challenges for the treatment of inflammatory skin diseases. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40552157 | PubMed |
| 39493568 | Role of cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes pathway in diabetes and its complications. | World J Diabetes | 2024 | https://conductscience.org/library/papers/39493568 | PubMed |
| 39464745 | Review of Excessive Cytosolic DNA and Its Role in AIM2 and cGAS-STING Mediated Psoriasis Development. | Clin Cosmet Investig Dermatol | 2024 | https://conductscience.org/library/papers/39464745 | PubMed |
| 38312740 | The cGAS-STING pathway: a therapeutic target in diabetes and its complications. | Burns Trauma | 2024 | https://conductscience.org/library/papers/38312740 | PubMed |
| 37083899 | The Crucial Roles and Research Advances of cGAS-STING Pathway in Cutaneous Disorders. | Inflammation | 2023 | https://conductscience.org/library/papers/37083899 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL17A | 3605 | PubTator's text mining | https://conductscience.org/library/genes/3605 | NCBI Gene |
| STING1 | 340061 | PubTator's text mining | https://conductscience.org/library/genes/340061 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36835537
GET https://conductscience.org/api/papers/v1/36835537/references?page=2